logo

For the Inventor, By the Inventor

Fords, NJ, United States of America

Rachael Siegel

This inventor holds 6 USPTO granted patents. Top assignee: Medical Diagnostic Laboratories, LLC. Active years: 2013-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rachael Siegel. Retrieved from https://idiyas.com/inventor/rachael-siegel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 16.7

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal6 out of 80 
 
Medical Diagnostic Laboratories, LLC
 patents

Years Active: 2013-2018

Loading Chart...
6 patents (USPTO):Explore Patents
1. 10144974 - Methods and reagents that specifically detect, distinguish and quantify IFN-LAMBDA2 mRNA from IFN-LAMBDA3 mRNA in humans (2018-12-04),
2. 9850489 - Repressor on IFN-λ promoter and siRNA against GATA1, EVI1, and CRX to alter IFN-λ gene activity (2017-12-26),
3. 9506066 - Repressor on IFN-λ promoter and siRNA against GATA1, EVI1, and CRX to alter IFN-λ gene activity (2016-11-29),
4. 9464321 - Methods and reagents that specifically detect, distinguish and quantify IFN-λ2 mRNA from IFN-λ3 mRNA in humans (2016-10-11),
5. 9163238 - Repressor on IFN-λ promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-λ gene activity (2015-10-20),
6. 8349808 - Identification of a novel repressor on IFN-lambda promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-lambda gene activity (2013-01-08),

Title: Rachael Siegel: Innovator in Molecular Diagnostics

Introduction

Rachael Siegel is a prominent inventor based in Fords, NJ (US). She has made significant contributions to the field of molecular diagnostics, holding a total of 6 patents. Her work focuses on innovative methods for detecting and quantifying specific mRNA in humans, which has important implications for medical diagnostics and treatment.

Latest Patents

Rachael's latest patents include groundbreaking methods and reagents that specifically detect, distinguish, and quantify IFN-LAMBDA2 mRNA from IFN-LAMBDA3 mRNA in humans. This invention provides a qRT-PCR method that allows for the specific detection and quantification of these mRNA types in biological samples. Additionally, she has developed a method involving siRNAs against ZEB1 and BLIMP-1 mRNAs to enhance the activity of the IFN-LAMBDA1 promoter, which can promote an anti-viral response and potentially treat various diseases.

Career Highlights

Rachael Siegel is currently associated with Medical Diagnostic Laboratories, LLC, where she continues to advance her research and innovations. Her work has been instrumental in improving diagnostic techniques and therapeutic applications in the medical field.

Collaborations

Some of her notable coworkers include Grant E Gallagher and Joyce Eskdale, who have collaborated with her on various projects, contributing to the success of her inventions.

Conclusion

Rachael Siegel's contributions to molecular diagnostics through her innovative patents highlight her role as a leading inventor in the field. Her work not only enhances our understanding of mRNA detection but also paves the way for new therapeutic approaches.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…